Please assess the completion status of the following clinical trial:

Trial Title: Safety and Immunogenicity of a New Formulation of a Bivalent Killed, Whole-Cell Oral Cholera Vaccine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Healthy non-pregnant adults~* Available in the study area for 1 month~Exclusion Criteria:~* Diarrhea for the past week~* Antibiotic use in the past week~* Intake of anti-diarrheal medicines in the past week~* One or more episodes of diarrhea or abdominal pain lasting for 2 weeks during the past 6 months~* Abdominal pain, nausea, vomiting, loss of appetite or generalized ill feeling for the past 24 hours~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).